Cortical activity evoked by inoculation needle prick in infants up to one-year old by Verriotis, M et al.
Research Paper
Cortical activity evoked by inoculation needle prick
in infants up to one-year old
Madeleine Verriotis
a,*, Lorenzo Fabrizi
a, Amy Lee
a, Sheryl Ledwidge
a, Judith Meek
b, Maria Fitzgerald
a
Abstract
Inoculation is one of the first and most common experiences of procedural pain in infancy. However, little is known about how
needlepuncturepainisprocessedbythecentralnervoussysteminchildren.Inthisstudy,wedescribeforthefirsttimetheevent-
relatedactivityintheinfantbrainduringroutineinoculationusingelectroencephalography.Fifteenhealthyterm-borninfantsaged
1t o2m o n t h s( n5 12) or 12 months (n 5 5) were studied in an outpatient clinic. Pain behavior was scored using the Modified
Behavioral Pain Scale. A distinctinoculation event–related vertexpotential,consisting of 2late negative-positivecomplexes, was
observable in single trials after needle contact with the skin. The amplitude of both negative-positive components was
significantly greater in the 12-month group. Both inoculation event–related potential amplitude and behavioral pain scores
increased with age but the 2 measures were not correlated with each other. These components are the first recordings of brain
activity in response to real-life needle pain in infants up to a year old. They provide new evidence of postnatal nociceptive
processing and, combined with more traditional behavioral pain scores, offer a potentially more sensitive measure for testing the
efficacy of analgesic protocols in this age group.
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1. Introduction
Inoculations are the most common source of procedural pain in
infants and children.
25 In recent years, development of clinical
pain assessment tools for preverbal infants such as the Modified
Behavioral Pain Scale (MBPS)
39 has enabled a large body of
research into improved methods of vaccine administration
18 and
pain relief strategies.
6,22,34,38 Such pain scales rely on somatic
and autonomic reflexes and behavioral measures such as body
movements, changes in heart rate, and in facial expression;
although these measures suggest that immunization injections
can cause significant levels of distress for children, they are only
indirect indicators of thepain perceived. Perception ofpain arises
in the brain and involves sensory–discriminative and affective–
motivational processing in the cortex,
24,41 therefore a brain-led
approach to assess procedural pain in preverbal infants could be
a viable way forward.
13
In line with this principle, our understanding of cortical pain
processing in neonates has been advanced by direct measure-
ment of brain activity in preterm and full-term infants through the
use of near-infrared spectroscopy
2,20,27,28 and scalp electroen-
cephalography (EEG).
8,29–31 Such studies have shown that
neonates are already capable of discriminating between noxious
and innocuous stimuli byterm age.
8,31 However, itis stillnot clear
howcorticalsomatosensoryandnociceptiveprocessingmatures
in the early postnatal period.
Previous EEG studies have identified a specific pattern of
corticalactivity afternoxiousheellance inhumanneonates.
8,30,31
Here, we have recorded time-locked EEG during a routine
inoculation in infants during the first year of life and characterized,
for the first time, the infant EEG response to inoculation. This
approach could provide insight into cortical pain processing of
a wider range of real-life painful procedures in young infants and
also provide a useful objective measure of procedural pain for
testing analgesic protocols.
2. Methods
2.1. Participants
Fifteenhealthyterm-borninfantswerestudiedat1to2months
(n 5 12) or at 12 months (n 5 5) of age. Two infants were
studied at both ages, and 1 infant was studied at both 1 and 2
months. In addition, 1 infant was also studied at 6.5 months
and 2 infants received 2 inoculations on the same test
occasion; the inoculation at 6.5 months and the second
inoculations were not included in the final sample but are
presented individually. Infants were recruited from outpatient
clinics at the Elizabeth Garrett Anderson Wing, University
CollegeLondonHospital.Infantswerenoteligibleforinclusion
in the study if they were asphyxiated at birth or were receiving
medication at the time of study.
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medical records (Table 1). All infants were singletons and were
assessed by a doctor or nurse as clinically well at the time of
study.
Ethical approval for this study was given by the University
College London Hospital ethics committee. Informed written
parental consent was obtained before each study. The study
conformed to the standards set by the Declaration of Helsinki.
2.2. Noxious stimulus
The noxious stimulus was a needle puncture as part of a clinically
required routine inoculation administered intramuscularly into the
thigh by a nurse or doctor. No inoculations were given solely for
the purpose of the study. Most infants received a hepatitis B
inoculation, which is given at birth and again at 1, 2, and 12
months. The remaining infants received routine inoculations,
including DTaP/IPV/Hib, MenC, pneumococcal conjugate vac-
cine (PCV), and measles–mumps–rubella vaccine (MMR). Age
ranges studied reflect inoculation schedules in the United
Kingdom (Table 1). In all cases, infants received 0.5 mL fluid
and a 25-gauge needle was used. For all inoculations, standard
clinical practice guidelines
32 and hospital practice were followed:
all infants were either held by their parent or sitting upright in their
parent’slap,andweredistractedasrequired.Inaddition,parents
were encouraged to feed their child during the procedure; except
fortwo1-to2-month-olds,allinfantswerefedeitherduringorjust
before inoculation. Following hospital practice, no local anes-
thetic was used. For infants receiving 2 vaccinations on the same
occasion, the vaccine considered to be most painful was given
last, according to published guidelines
17,32; all intramuscular
inoculations were given rapidly without aspiration.
Inoculation is a complex stimulus involving several stages:
initial skin contact by the needle, increasing needle pressure on
theskinuntilitispunctured,fluidinjection,andneedlewithdrawal.
Here, we have focused on skin contact because this is the first
event from which the whole inoculation process follows, and
because it is less variable across different vaccines and fluid
volumes. To enable time-locking of the first skin contact with the
ongoing EEG, inoculation was filmed with a high-speed camera
(Optronis GmbH, Kehl, Germany; frame rate 5 200 frames per
second), which was synchronized with the EEG recording. The
frame in which the needle first contacted the skin was identified
post acquisition by 2 independent observers, and the corre-
sponding EEG segment was then analyzed (Fig. 1). First, contact
wasdefinedasthetimeatwhichtheskinwasfirstvisiblyindented
by the needle; this contact could be reliably identified by both
observers. To characterize the duration of the inoculation event,
the times at which (1) the needle broke the skin, (2) fluid injection
began,and(3)theneedleexitedtheskinwerealsoidentified.Skin
break was defined as the frame subsequent to maximal skin
indentation by the needle; fluid injection was defined as the frame
at which the plunger first began to move.
On average, the inoculation lasted 4924 6 1256 milliseconds
from the time of the first contact to the time the needle was
withdrawn from the skin. The skin was broken by the needle
approximately 418 6 162 milliseconds, and fluid injection began
2379 6 1306 milliseconds, after the first contact.
2.3. Pain behavior scoring
Pain behavior was assessed using the Modified Behavioral Pain
Scale (MBPS),
39 which is a validated
35 and extensively used
method of assessing inoculation pain.
5,17,18,22,34,38 The MBPS is
based on 3 parameters (facial expression, cry, and movements),
andscoresrangefrom0(nopain)to10(maximalpain).Infantswere
video recorded during the inoculation procedure using a standard
handheld camcorder, and baseline and inoculation periods were
identifiedofflineforpainbehaviorscoringasthe15secondsbefore
and the 15 seconds after the first needle contact with the skin.
Baseline and inoculation scores reflected the maximum response
observed during the respective 15-second periods. Videos were
scored by 2 independent observers and their interrater reliability
was assessed by calculating the intraclass correlation coefficient,
using a 2-way mixed model based on absolute agreement. This
model takes into account the systematic differences between
observers. This produced correlation coefficients of 0.81 and 0.89
for the baseline and inoculation periods, respectively, suggesting
a high interrater reliability of MBPS scores. Differences between
observers were small, and scores were averaged to produce
a single set of ratings.
2.4. EEG recording
Recording electrodes (disposable Ag/AgCl cup electrodes) were
positioned according to the modified international 10/20 elec-
trodeplacementsystematFp1,Fp2,Fz,F3,F4,Cz,C3,C4,CPz,
CP3, CP4, T3, T4, T5, T6, O1, O2, and POz. As recordings were
performed on volunteers, it was not always possible to apply the
full set of electrodes. The minimum number of electrodes used
was 6, although in the majority of infants, at least 11 electrodes
were used, and the Cz electrode was used in all recordings.
Reference and ground electrodes were placed at FCz and on the
forehead, respectively. Electrode-skin impedance was kept to
aminimumbyrubbingtheskinwithanEEGpreppinggel(NuPrep
gel; DO Weaver and Co, Aurora, CO), and contact with the
electrodes was optimized by applying conductive EEG paste
(Ten20; DO Weaver and Co, Aurora, CO or Elefix; Nihon Kohden,
Chessington, United Kingdom). Electrodes were held in place
using an elastic net (Surgifix; FRA Production S.p.A., Cisterna
d’Asti, Italy), and electrode leads were tied together to minimize
electrical interference. Electroencephalographic activity, from DC
to 70 Hz, was recorded using the Neuroscan (Scan 4.3)
SynAmps2 EEG/EP recording system (Compumedics Neuro-
scan, Charlotte, NC). A 50-Hz notch filter was used in all but 1
occasion,andsignalsweredigitizedwithasampling rateof2kHz
and a resolution of 24 bit.
All EEG recordings were assessed as normal by a trained
neurophysiologist (A.L.) with respect to symmetry, synchronicity,
absence of epileptiform activity, and background rhythms
appropriate for age. The infants’ sleep state was also classified
Table 1
Demographic characteristics of participating infants.*
1- to 2-month-olds
(N 5 12)
12-month-olds
(N 5 5)
Total inoculations 13 5
Age at birth, completed wk 38.9 (1.7) 40.0 (1.2)
Age at study, mo 1.4 (0.6) 12.3 (0.3)
No. of female infants 6/12 3/5
No. of right side inoculations 7/13 2/5
No. of hepatitis B inoculations 12/13 4/5
Weight at birth, g 3242 (486) 3764 (566)
No. of cesarean deliveries 5/12 1/5
APGAR score at 1 min 8.5 (1.8) 8.2 (1.3)
APGAR score at 5 min 9.8 (0.5) 9.8 (0.5)
* Data are mean (SD) or n/N and refer to number of infants unless otherwise indicated.
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infants were awake except one 2-month-old infant; 3 infants in
the 1- to 2-month-old group could not be classified.
2.5. Event-related potential analysis
Electroencephalography traces were analyzed using EEGLAB
7
and custom-written MATLAB (The MathWorks, Inc, Natick, MA)
scripts. Traces were bandpass filtered between 1 and 30 Hz
(using a second-order bidirectional Butterworth filter), initially
segmented into 2.7 second epochs starting from 0.6 seconds
before the first needle contact, and baseline-corrected using
a prestimulus interval of 20.5 to 0 seconds. Channels containing
movement artifact (defined as activity exceeding 6100 mV) or
high-frequency muscle activity were removed. In a single channel
of 1 trial, alpha activity was detected and filtered out using
a second-order bidirectional Butterworth stop-band filter be-
tween 7.5 and 12.5 Hz.
2.5.1. Within-group analysis
Previous research has found modality-specific significant differ-
ences in evoked activity at Cz and CPz only,
31 therefore in this
study, the analysis focused on Cz. Electroencephalography
segments were analyzed separately for the 2 age groups (1- to
2-month-olds vs 12-month-olds). In both groups, it was
possible to identify 2 waveforms maximal at Cz from the group
averages and from most individual trials. For each waveform,
traces were aligned to correct for latency jitter
4,44 using Woody-
filtering with an alignment window centered on the given
waveform. This approach resulted in 2 (aligned) group averages
per age group, which were used in subsequent analyses.
Because inoculation is a protracted and complex stimulus, we
allowed for a maximum jitter correction of 6 150 milliseconds.
Following Woody-filtering, traces were re-epoched between
20.5 and 2.0 seconds and baseline-corrected between 20.5
and 0 seconds.
To determine whether the waveforms were significantly
different from baseline, z tests were performed at each time
point within a region of interest centered on each waveform. We
used the false discovery rate
3 to correct for multiple comparisons
and assumed 30 independent tests per second because data
were lowpass filtered at 30 Hz. Scalp topography maps were
created from the aligned group averages to display the scalp
distribution of the negative (N) and positive (P) peaks of each
waveform.ForeachNandPpeak,theaverageamplitude(across
trials) at Cz and at each of the other channels at the time of the
given peak was plotted as a heat map. Channels that were
excluded because of contamination by artifacts or not recorded
were interpolated.
2.5.2. Between-group analysis
To determine whether cortical EEG responses differed with age,
the peak-to-peak amplitude (of the N and P peaks, which were
manually identified in theindividual traces bycomparison with the
groupaverages)ofeachwaveform wascompared acrossgroups
using independent samples t tests. In addition, the aligned EEG
traces of the 1- to 2- and 12-month-old infants were compared,
separately for each of the 2 waveforms, to detect which parts of
the waveform were significantly different between the 2 groups.
To enable comparison of the magnitude of the waveforms, the
EEGtracesofthe1-to2-month-oldswerealignedwithrespectto
those of the 12-month-olds (without affecting within-group
alignment) using Woody-filtering with a maximum jitter of 6100
milliseconds. Independent samples t tests were then performed
at each time point, within a region of interest centered on each
waveform, to test whether the distribution of amplitudes of each
group at the given time point were significantly different.
Corrections for multiple comparisons were performed as de-
scribed in Section 2.4.1.
2.6. Statistical analysis
Data were assessed for normality and homogeneity of variance.
Where assumptions for a parametric test were not met, a non-
parametric test was used and the median and interquartile range
(quartile 1-quartile3)werereported. Foralltests, thethresholdfor
significance was set at a 5 0.05, except where adjusted for
multiple comparisons.
Figure 1. Method for time-locking the inoculation event to the electroencephalography (EEG) recording. Electroencephalographic activity recorded at electrode
positionCzina2-month-oldinfantisshown.Theexacttimeatwhichtheneedlefirstcontactedtheskinoftheinfant’sleftthigh(time0,redline)wasobtainedusing
a high-speed camera (200 frames per seconds) that was synchronized with the EEG recording. The 5-millisecond frames pictured above the EEG trace
correspond to the first contact (0 milliseconds) and to 10 and 20 milliseconds before and after (gray region around 0).
224 M. Verriotis et al.·
156 (2015) 222–230 PAIN®3. Results
Inoculation elicited a clear event-related potential, consisting of 2
waveforms recorded at Cz. These potentials were observable in
single trials after first contact of the needle with the skin (Fig. 2).
Thewaveformswerepresentinbothagegroups(1-2monthsand
12 months) and were reproducible across infants, particularly in
the older group.
3.1. Characterization of the EEG response to inoculation in
1- to 2-month-olds
In the 1- to 2-month group, inoculation evoked an event-related
potential (iERP), which consisted of a clear late N1P1 complex
followed by a less clear N2P2 complex. Traces were aligned (and
tested for significance) between 50 and 500 milliseconds for the first
waveform and between 550 and 900 milliseconds for the second
waveform. Both waveforms were significantly different from
baseline. The mean latencies of the N and P peaks of the first
waveform were 234 6 49 and 395 6 17 milliseconds, and the
amplitudeswere211612and21616mV,respectively.Themean
latencies of the N and P peaks of the second waveform were 642 6
34 and 792 6 26 milliseconds and 218 6 9a n d1 06 11 mV,
respectively(Table2).Scalptopographymapsshowedthatforboth
waveforms, the N and P peaks were maximal at the vertex (Fig. 3).
3.2. iERPs can also be recorded in older infants
Inoculation also evoked a clear iERP in the 12-month group,
consisting of 2 clear late negative-positive (NP) complexes that
were similar to those evoked in the 1- to 2-month group (Fig. 4).
Both waveforms were strikingly reproducible across infants
and could be clearly identified in every single trial (Fig. 2). Traces
were aligned between 200 to 600 milliseconds and 400 to
1100 milliseconds for the first and second waveforms, respectively.
As before, both waveforms were significantly different from baseline
(tested between 200 and 600 milliseconds for the first waveform
andbetween550and1100millisecondsforthesecond).Themean
N1 and P1 peaks were 371 6 18 and 507 6 26 milliseconds in
latencyand245622and3969mVinamplitude,respectively.For
thesecondwaveform,themeanNandPpeakswere616614and
761 645 milliseconds in latency and 218 625 and 41 612 mVi n
amplitude, respectively (Table 2). Scalp topography maps revealed
that similar to the 1- to 2-month group, the P peaks of both
waveformsweregenerallylocalizedtothevertex.TheNpeakswere
not as localized to the vertex as in the 1- to 2-month-olds; this is
l i k e l yt ob ed u et ot h es m a l ls a m p l es i z ea n dt h ee x c l u s i o no fs o m e
channels from most trials (Fig. 4).
3.3. The iERP is reproducible in individual infants
The iERP could be clearly observed in single trials (Fig. 2). In
addition, in 2 infants where 2 inoculations were scheduled on the
same test occasion, both waveforms were reproducible across
the 2 inoculations (Fig. 5).
3.4. The iERP is larger at 12 vs 1 to 2 months of age
Although theiERPcouldbeobservedinsingletrialsinbothgroups,
itwasclearerandmorereproducibleacrossinfantsinthe12-month
group, and both waveforms were larger in this group (Fig. 2).
Independent samples t tests comparing the peak-to-peak
amplitude of each waveform across groups confirmed that the
12-month-olds had significantly larger peak-to-peak amplitudes
thanthe1-to2-month-oldsforboththefirst(meanamplitude:846
23 vs 32 624 mV; t(16) 5 4.20, P 5 0.001) and second (58 629 vs
28 6 13 mV; t(16) 5 3.08, P 5 0.007) waveforms (Fig. 6).
To further explore the increase in amplitude with age, the EEG
traces were compared directly to determine which parts of the
waveforms differed between the 2 groups. Independent samples
t tests at each time point within 150 to 600 milliseconds for the
first waveform and 550 to 1100 milliseconds for the second
waveform showed that N1 and P2 were significantly larger at 12
months of age (Fig. 7).
Figure 2. Single-trial electroencephalography responses to inoculation,
recorded from Cz, after the first contact with the inoculation needle (at time 0;
vertical line) in the 12-month-olds (right) and, for comparison, 5 of the clearest
responsesinthe1-to2-monthgroup(left).Notethestrikingreproducibilityinthe
older group. Traces marked with an asterisk belong to a single infant that was
studiedlongitudinallyatbothages.Tracesareshownwithoutalignmenttoeither
the firstorsecond waveforms. Arrowspoint to the first (gray arrows) andsecond
(black arrows) waveforms that were identified in individual trials after alignment
(see Figures 3 and 4 for aligned group average responses).
Table 2
Peak latency and amplitude and peak-to-peak amplitude of
the iERP.*
1- to 2-month-olds 12-month-olds
N1
Amplitude, mV 211 6 12 245 6 22
Latency, ms 234 6 49 371 6 18
P1
Amplitude, mV2 1 6 16 39 6 9
Latency, ms 395 6 17 507 6 26
N1P1 amplitude, mV3 2 6 24 84 6 23
N2
Amplitude, mV 218 6 9 218 6 25
Latency, ms 642 6 34 616 6 14
P2
Amplitude, mV1 0 6 11 41 6 12
Latency, ms 792 6 26 761 6 45
N2P2 amplitude, mV2 8 6 13 58 6 29
* Data are mean 6 SD.
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longitudinally in individual infants
The increase in amplitude and clarity of the iERP can also be
observed in individual infants studied on multiple occasions. Two
infants were studied at both 1 to 2 months and 12months ofage,
and one 12-month-old infant was also studied at 6.5 months. In
all 3 infants, the EEG response appeared clearer and larger by 12
monthsofage,particularlyforthefirstwaveform(Fig.2,asterisks;
Fig.S1,availableonlineasSupplementalDigitalContentathttp://
links.lww.com/PAIN/A4).
Figure3.Average(6SD)inoculationevent–relatedpotential(iERP)afterthefirstneedlecontact(attime50milliseconds;verticalline)in1-to2-month-olds(n513
inoculationsfrom12infants;seeMethodsandTable1)whenalignedbetween50and500milliseconds(left)and550and900milliseconds(right),withtopography
mapsatthenegative(N)andpositive(P)peaks.Notethatthegroupaverageresponsesarefromthesamegroupofinfantsbutlookdifferentbecausetheindividual
trials have been aligned differently. After aligning for the second waveform (right), the first waveform (gray arrow) is still visible, although less clearly.
Figure 4. Average (6SD) iERP in 12-month-olds (n 5 5) when aligned between 200 and 600 milliseconds (left) and 400 to 1100 milliseconds (right), with
topographymapsatNandP.Notethatsimilartothe1-to2-month-olds,thefirstwaveform(grayarrow)isstillvisibleafteralignmenttothesecondwaveform(right);
in addition, the second waveform (black arrow) is also visible after alignment to the first waveform (left). iERP, inoculation event–related potential.
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pain behavior
Both groups of infants exhibited little pain behavior before
inoculation (median [Q1-Q3] MBPS scores 5 2.0 [2.0-2.0] for
1- to 2-month-olds and 2.0 [1.0-2.0] for 12-month-olds) and
responded strongly during the inoculation period (8.0 [7.5-8.0]
and 9.0 [9.0-9.0], respectively). In line with the iERP amplitudes,
theMBPSscoresduringtheinoculationweresignificantlylargerin
the older infants (Wilcoxon–Mann–Whitney test; mean rank 15.0
vs 7.4 in 12-month vs 1-to 2-month-olds, respectively; Z 5 2.93,
P 5 0.002; Fig. 8). However, examination of the relationship
between cortical EEG responses and pain behavior revealed no
correlation between the peak-to-peak amplitudes of either the
first or second waveforms and the inoculation MBPS scores in
1- to 2-month-olds (Spearman rank order correlation coefficient;
waveform 1: r 52 0.15, P 5 0.62 and waveform 2: r 52 0.20,
P 5 0.52; n 5 13). This relationship could not be explored in the
12-month-olds because all infants had identical scores (Fig. 8).
4. Discussion
Our data show that inoculation elicits clear event-related
potentials (iERPs) after first needle contact in infants aged
1 to 2 and 12 months and that the iERPs increase in clarity and
amplitude by 12 months.
In both groups, the iERP consisted of 2 biphasic negative-
positive waveforms maximal at the vertex. The iERP could be
identified in single trials and was reproducible both across infants
and within infants that were given successive inoculations,
confirming its reliability.
4.1. Interpretation of iERPs
Inoculation is a protracted, complex stimulus, consisting of an
initial phase in which the needle contacts the skin and increasing
pressure is applied until the skin is broken, followed by needle
penetration deeper into the muscle, fluid injection, and needle
withdrawal. Because fluid injection occurred at a mean of ;2.4
seconds after the first needle contact, it is likely that the first
waveform, if not also the second, is related mainly to needle
contact and needle pressure.
Two studies have explored related stimuli in adult partic-
ipants.
4,14Inthefirst,asmall-diameterPlexiglassprobewasused
toapplydifferentlevelsofmechanicalforcetothefingernailbed.
4
When the pressure applied was perceived as painful, a potential
was elicited at Cz consisting of 2 waveforms that were strikingly
similartotheiERPintermsofpolarityandscalpdistribution.Inthe
second study, needle-like pressure was applied using a small-
diameter flat-tip mechanical stimulator (the PinPrick). This
approachevokedasinglebiphasicNPcomplexthatwasmaximal
at Cz.
14 Although the pinprick-evoked potential consisted of only
1 waveform, this was also similar in terms of topography and
polarity to the waveforms elicited after inoculation. Latencies of
the waveforms reported in adults
4,14 were shorter than those
reported here; this tendency could be explained by slower
conduction velocities and longer synaptic delays in the immature
nervous system.
19,40 It should also be noted that both adult
studies report the average waveform from 20 to 40 repeated
stimuli per site, which greatly reduces variability. Here, we are
studying a real-life, one-off painful event in a clinical setting, and
yet we are able to detect a clear response.
In the first adult study, the second waveform was elicited only
when the pressure applied was reported as painful,
4 whereas in
preverbal children, this information is not available; the use of
calibrated needle-like stimulators (the PinPrick) with a range of
forces may provide us with more information. In addition,
although needle pressure and needle puncture are noxious, fluid
injectionisalsoconsideredpainfulandfutureworkcouldfocuson
Figure 5. Single-trial iERPs in 2 infants having consecutive inoculations on the
same test occasion. Infant 1 had 2 inoculations at 2 months (blue traces), and
infant 2 had 2 inoculations at 6.5 months (black traces); the first inoculation is
plottedfirst(uppertrace).Inbothinfants,the2waveforms(grayandblackarrows
as in Figure 2) are very reproducible. Traces are shown without alignment.
Figure 6. Column scatterplots showing the peak-to-peak amplitudes of the first (left) and second (right) waveforms for 1- to 2-month-olds (blue; n 5 13) and 12-
month-olds(red;n55).Forbothwaveforms,1-to2-month-oldshadlowerpeak-to-peakamplitudesthan12-month-olds.Themean(solidhorizontalline)andSD
(whiskers extending from the mean) are indicated. **P , 0.01; ***P , 0.005.
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cortical response to inoculation.
4.2. Comparison with heel lance in neonates
We have previously characterized the EEG response to a noxious
heellanceinneonates.
8,31Althoughthisisaninstantaneousskin-
breaking event, unlike the inoculation, the iERP was similar in
morphology, polarity, and topography to the potential elicited by
heel lance in term-age neonates.
31 In the neonates, heel lance
also elicited 2 waveforms, of which only the second was
nociceptive specific.
31
Both waveforms had longer latencies after inoculation (1- to 2-
month-olds: N234-P395 and N642-P792; 12-month-olds:
N371-P507 and N616-P761) as compared with heel lance
(N150-P260 and N420-P560).
31 This may be due in part to the
greater variability ofthe inoculation as a stimulus but is more likely
to represent the delay between the first needle contact and the
time at which needle pressure becomes noxious.
4.3. Postnatal development
Comparison of the peak-to-peak amplitudes with age showed
that both waveforms were significantly larger in the 12-month-
olds.Physiologically, this phenomenon could be explained by the
presence of a larger population of neurons, or by a larger
proportion of the neural population being recruited, in older
infants. Alternatively, it could be explained by better synchroni-
zation of firing activity of the neurons being recruited, resulting in
better signal-to-noise ratio.
The larger magnitude of the iERPs in the older infants may also
be due to increased exposure to tissue damaging stimuli in the
older group, which typically had at least 1 to 2 more inoculations
than the younger infants, without considering all the other
common injuries that infants experience in daily life. We have
previously shown that prematurity, and the resulting early
exposure to noxious procedures, is associated with larger
amplitude nociceptive EEG responses to noxious heel lance.
30
This finding is also consistent with studies suggesting that
exposure to painful procedures in early infancy results in
prolonged changes in pain sensitivity.
12,23,26,37,42
When comparing EEG traces directly, we found that the
increase in amplitude of the iERP was restricted to the N1 and P2
peaks.Severalstudiesexploringsomatosensoryvertexpotentials
in adults have also found amplitude changes that are specific to
either the N or P peak. In 2 studies in which mechanical
stimulation was applied, the amplitude of the P peak increased
after noxious lance vs innocuous sham stimulation
9 and after
painful vs nonpainful mechanical force application.
4 In contrast,
Iannetti et al.
14 reported an increase in amplitude after
mechanical pinprick stimulation that was restricted to the N peak
of the pinprick-evoked potential during capsaicin-induced hyper-
algesia in adults, and also found that the N peak of laser-evoked
potentialsrecordedinadultparticipantscorrelatesbetterthanthe
P peak with perceived intensity of the noxious laser stimulation.
15
Itisnotclearat presentwhethertheamplitudechangesobserved
in the iERP are also related to nociception. Further research is
needed to better characterize the different components of the
iERP, and longitudinal study of a larger group at several ages will
also provide more insight into the development of nociceptive
processing in infants.
Although the iERP was larger and clearer in the older group,
topography maps ofthe N peaks were less localized to Cz than in
the youngergroup.One possibilityis that inthis group,thesignal-
to-noise ratio is larger and therefore the response is picked up
from more electrodes; another possibility is that while EEG
responses become more localized with age, there is a de-
velopmental period where they appear less localized. Finally, this
phenomenon could also be due to the smaller sample size and
the exclusion of some channels in most trials.
Figure 7. Statistical comparison of the electroencephalography traces of 1- to 2-month-olds (blue) and 12-month-olds (red) for the first (left) and second (right)
waveforms. For each waveform, traces were aligned between groups (without affecting within-group alignment). Independent samples t tests assessed whether
the distribution of amplitudes at each time point in a region of interest centered on the waveform (150-600 milliseconds for the first waveform; 550-1100
milliseconds for the second waveform) differed between the 2 groups. The aligned group averages (6SD) are shown, with statistically significant differences
highlighted in gray.
Figure 8. Column scatterplots showing the inoculation Modified Behavioral
Pain Scale (MBPS) scores of 1- to 2-month-olds and 12-month-olds. Note the
narrow range of scores in both groups. The median (solid horizontal line) and
interquartile range (whiskers extending from the median) are indicated.
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In the absence of self-report, pain in preverbal infants is typically
assessed using scales that rely on behavioral and autonomic
responses. Here,we usedtheMBPS, whichfocusesonthe facial
expression, crying, and body movements. We found no relation-
ship between the cortical EEG response and pain behavior in 1-
to 2-month-olds, perhaps because MBPS scores were invariant
in comparison with peak-to-peak amplitudes, with most infants
scoring almost maximally (8/10) after inoculation (Figs. 6, 8).
Pain scales are a useful tool for research into interventions that
reduce inoculation pain in young infants,
6,17,18,22,34,38 and facial
expression in particular is considered a reliable pain response
10,11
that is important for communication with others to enable relief or
escape.
43 Nonetheless, the low spread of MBPS scores in our data
suggests that the behavioral responses on which the MBPS is
based are a relatively “blunt” measure of the subjective pain
experience, perhaps because of their importance for communica-
tion with others to enable immediate action for pain relief or
avoidance. Cortical EEG activity, however, shows that the noxious
stimulus is being processed in the brain, with some individual
variability, but is not necessarily a direct read-out of the amount of
pain perceived. In any case, given that the perception of pain arises
inthecortex,itislikelythatabrain-orientedapproachwouldprovide
useful information in conjunction with pain behavior that could be
used to investigate the efficacy of pain-relieving interventions.
4.5. Clinical relevance
Inoculations are the most common cause of childhood pro-
cedural pain. Bythe ageof2,14to 20injectionsare administered
in the United States
25 and 9 in the United Kingdom.
16 Pain
associated with frequent inoculations is a source of anxiety and
distressforthechild,butisalsooftenaconcernfortheparentand
clinician,
25,33 and there is emerging evidence that fear of needles
in both parents and children affects compliance with medical
care.
1,21,33,36,45 Improved pain management during routine
inoculation is therefore an important goal.
33 Our ability to record
clear EEG responses to inoculation is a first step toward
characterizing a cortical pain response that could be useful in
assessing pain management strategies during inoculation.
4.6. Conclusion
Here,wehaveshownthatinoculationevokes,fromthetimeofthe
first needle contact, a clearly defined EEG response in infants up
to at least 1 year of age. This finding may provide a quantitative
measure of cortical pain activity that could be used to investigate
the efficacy of pain-relieving interventions. The technique used to
time-lock the inoculation procedure to the EEG recording
extends the range of real-life painful events we can study and
allows us to explore the long-term postnatal development of
nociceptive processing in the infant brain.
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